Latest News
-
Elon Musk Postpones India Trip, Tesla's Indian Market Entry Delayed -
HDFC Bank Q4 Results: Net Profit Rises 37% To Rs 16,512 Cr; Rs 19.5 Dividend Declared -
Gold Prices: 10-Gram 24-Carat Rises Rs 8,010 Before Falling; Chennai Gold Price At Rs 75,110 -
Defence Stock Set To Become Cheaper, 1:5 Split Approved: Shares Zoom 406% In 1-Yr -
Indian Railways Announces Historic Increase in Summer Train Trips -
62-Yrs Old Fertilizers PSU Set To Recommend Dividend Rewards, Rises 78% In 1-Yr; Yield 4.49% -
Want To Be Debt Free? 5 Simple Ways To Repay Your Loan Faster -
1:2 Stock Split, Dividend 100%, Net Soars 52.56%: Engineering Stock Soars 1576% In 3-Yrs -
Senior Citizens Benefits: Top Banks Offer High FD Interest Rates -
How Will Bitcoin Halving 2024 Impact Bitcoin?
Marksans Pharma Gains on Agreement with Bond Holders
Shares of Marksans Pharma gained more than 5 percent on Monday after the company said that it has signed settlement agreement with few bond holders for 36,789 bonds.
"The company had signed settlement agreement with few bond holders for settlement of the then outstanding 36,789 bonds of USD 1,000 each in principal value. Out of that 21,511 bonds have already been settled and cancelled," the phrama company said in its filing.
The company had earlier filed a suit in the High Court of England seeking specific performance by the bond holder in accordance with the settlement agreement. Further, it said the court disposed off tand said the suit in favour of the company.
Consequently, after execution of 15,278 bonds settlement, only 61 bonds of USD 1,000 each (out of the total issued 50,000 bonds) will remain outstanding.
Shares of the Marksans Phrama was seen trading at Rs 60.45, higher by 2.89 per cent on BSE at 12.30 PM IST. It touched an intra-day high of Rs 62.40 during the trade.
GoodReturns.in
